カテゴリ： 世界, 医療/バイオ, QYResearch

臨床開発サービス（CDS）の世界市場インサイト・予測（～2028年）

■ 英語タイトル：Global Clinical Development Services Market Insights, Forecast to 2028

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QY22JL3855）■ 発行会社/調査会社：QYResearch
■ 商品コード：QY22JL3855
■ 発行日：2022年7月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：127
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[臨床開発サービス（CDS）の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

COVID-19のパンデミックにより、臨床開発サービス（CDS）のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に臨床開発サービス（CDS）の世界市場のxxx％を占める「生物統計学」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「製薬会社」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
臨床開発サービス（CDS）の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの臨床開発サービス（CDS）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

臨床開発サービス（CDS）のグローバル主要企業には、Syneos Health、PPD、GVI CDS、Parexel、Clinical Leader、Thermo Fisher Scientific、LabCorp、Worldwide Clinical Trial、CROS NT、Dynakin、Rho, Inc.、Synteract、ICBio CRO、Sofpromed、Profil、ICON plc、Clinipace、OCT Clinical、EPS Group、Beijing Sun-novo Pharmaceutical Research、Dmedglobal、WuXi AppTec、Elixir Clinical Research、IBMなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

臨床開発サービス（CDS）市場は、種類と用途によって区分されます。世界の臨床開発サービス（CDS）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
生物統計学、データ管理、臨床試験モニタリング、臨床試験プロジェクト管理（フェーズI-IV）、規制業務、ファーマコビジランス、その他

【用途別セグメント】
製薬会社、医療機器会社、委託研究機関

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 臨床開発サービス（CDS）製品概要
- 種類別市場（生物統計学、データ管理、臨床試験モニタリング、臨床試験プロジェクト管理（フェーズI-IV）、規制業務、ファーマコビジランス、その他）
- 用途別市場（製薬会社、医療機器会社、委託研究機関）
- 調査の目的
・エグゼクティブサマリー
- 世界の臨床開発サービス（CDS）販売量予測2017-2028
- 世界の臨床開発サービス（CDS）売上予測2017-2028
- 臨床開発サービス（CDS）の地域別販売量
- 臨床開発サービス（CDS）の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別臨床開発サービス（CDS）販売量
- 主要メーカー別臨床開発サービス（CDS）売上
- 主要メーカー別臨床開発サービス（CDS）価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（生物統計学、データ管理、臨床試験モニタリング、臨床試験プロジェクト管理（フェーズI-IV）、規制業務、ファーマコビジランス、その他）
- 臨床開発サービス（CDS）の種類別販売量
- 臨床開発サービス（CDS）の種類別売上
- 臨床開発サービス（CDS）の種類別価格
・用途別市場規模（製薬会社、医療機器会社、委託研究機関）
- 臨床開発サービス（CDS）の用途別販売量
- 臨床開発サービス（CDS）の用途別売上
- 臨床開発サービス（CDS）の用途別価格
・北米市場
- 北米の臨床開発サービス（CDS）市場規模（種類別、用途別）
- 主要国別の臨床開発サービス（CDS）市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの臨床開発サービス（CDS）市場規模（種類別、用途別）
- 主要国別の臨床開発サービス（CDS）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の臨床開発サービス（CDS）市場規模（種類別、用途別）
- 主要国別の臨床開発サービス（CDS）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の臨床開発サービス（CDS）市場規模（種類別、用途別）
- 主要国別の臨床開発サービス（CDS）市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの臨床開発サービス（CDS）市場規模（種類別、用途別）
- 主要国別の臨床開発サービス（CDS）市場規模（トルコ、サウジアラビア）
・企業情報
Syneos Health、PPD、GVI CDS、Parexel、Clinical Leader、Thermo Fisher Scientific、LabCorp、Worldwide Clinical Trial、CROS NT、Dynakin、Rho, Inc.、Synteract、ICBio CRO、Sofpromed、Profil、ICON plc、Clinipace、OCT Clinical、EPS Group、Beijing Sun-novo Pharmaceutical Research、Dmedglobal、WuXi AppTec、Elixir Clinical Research、IBM
・産業チェーン及び販売チャネル分析
- 臨床開発サービス（CDS）の産業チェーン分析
- 臨床開発サービス（CDS）の原材料
- 臨床開発サービス（CDS）の生産プロセス
- 臨床開発サービス（CDS）の販売及びマーケティング
- 臨床開発サービス（CDS）の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 臨床開発サービス（CDS）の産業動向
- 臨床開発サービス（CDS）のマーケットドライバー
- 臨床開発サービス（CDS）の課題
- 臨床開発サービス（CDS）の阻害要因
・主な調査結果

Market Analysis and Insights: Global Clinical Development Services Market
The global Clinical Development Services market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Biostatistics accounting for % of the Clinical Development Services global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical Companies segment is altered to an % CAGR throughout this forecast period.
China Clinical Development Services market size is valued at US$ million in 2021, while the North America and Europe Clinical Development Services are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Clinical Development Services landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Development Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Development Services market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Development Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Development Services market.
Global Clinical Development Services Scope and Market Size
Clinical Development Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Clinical Development Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Biostatistics
Data Management
Clinical Trial Monitoring
Clinical Trial Project Management (Phase I-Iv)
Regulatory Affairs
Pharmacovigilance
Other
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Contract Research Organizations
By Company
Syneos Health
PPD
GVI CDS
Parexel
Clinical Leader
Thermo Fisher Scientific
LabCorp
Worldwide Clinical Trial
CROS NT
Dynakin
Rho, Inc.
Synteract
ICBio CRO
Sofpromed
Profil
ICON plc
Clinipace
OCT Clinical
EPS Group
Beijing Sun-novo Pharmaceutical Research
Dmedglobal
WuXi AppTec
Elixir Clinical Research
IBM
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

*** レポート目次（コンテンツ）***

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Development Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biostatistics
1.2.3 Data Management
1.2.4 Clinical Trial Monitoring
1.2.5 Clinical Trial Project Management (Phase I-Iv)
1.2.6 Regulatory Affairs
1.2.7 Pharmacovigilance
1.2.8 Other
1.3 Market by Application
1.3.1 Global Clinical Development Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical Development Services Market Perspective (2017-2028)
2.2 Clinical Development Services Growth Trends by Region
2.2.1 Clinical Development Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Clinical Development Services Historic Market Size by Region (2017-2022)
2.2.3 Clinical Development Services Forecasted Market Size by Region (2023-2028)
2.3 Clinical Development Services Market Dynamics
2.3.1 Clinical Development Services Industry Trends
2.3.2 Clinical Development Services Market Drivers
2.3.3 Clinical Development Services Market Challenges
2.3.4 Clinical Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Development Services Players by Revenue
3.1.1 Global Top Clinical Development Services Players by Revenue (2017-2022)
3.1.2 Global Clinical Development Services Revenue Market Share by Players (2017-2022)
3.2 Global Clinical Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Development Services Revenue
3.4 Global Clinical Development Services Market Concentration Ratio
3.4.1 Global Clinical Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Development Services Revenue in 2021
3.5 Clinical Development Services Key Players Head office and Area Served
3.6 Key Players Clinical Development Services Product Solution and Service
3.7 Date of Enter into Clinical Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Development Services Breakdown Data by Type
4.1 Global Clinical Development Services Historic Market Size by Type (2017-2022)
4.2 Global Clinical Development Services Forecasted Market Size by Type (2023-2028)
5 Clinical Development Services Breakdown Data by Application
5.1 Global Clinical Development Services Historic Market Size by Application (2017-2022)
5.2 Global Clinical Development Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Clinical Development Services Market Size (2017-2028)
6.2 North America Clinical Development Services Market Size by Type
6.2.1 North America Clinical Development Services Market Size by Type (2017-2022)
6.2.2 North America Clinical Development Services Market Size by Type (2023-2028)
6.2.3 North America Clinical Development Services Market Share by Type (2017-2028)
6.3 North America Clinical Development Services Market Size by Application
6.3.1 North America Clinical Development Services Market Size by Application (2017-2022)
6.3.2 North America Clinical Development Services Market Size by Application (2023-2028)
6.3.3 North America Clinical Development Services Market Share by Application (2017-2028)
6.4 North America Clinical Development Services Market Size by Country
6.4.1 North America Clinical Development Services Market Size by Country (2017-2022)
6.4.2 North America Clinical Development Services Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical Development Services Market Size (2017-2028)
7.2 Europe Clinical Development Services Market Size by Type
7.2.1 Europe Clinical Development Services Market Size by Type (2017-2022)
7.2.2 Europe Clinical Development Services Market Size by Type (2023-2028)
7.2.3 Europe Clinical Development Services Market Share by Type (2017-2028)
7.3 Europe Clinical Development Services Market Size by Application
7.3.1 Europe Clinical Development Services Market Size by Application (2017-2022)
7.3.2 Europe Clinical Development Services Market Size by Application (2023-2028)
7.3.3 Europe Clinical Development Services Market Share by Application (2017-2028)
7.4 Europe Clinical Development Services Market Size by Country
7.4.1 Europe Clinical Development Services Market Size by Country (2017-2022)
7.4.2 Europe Clinical Development Services Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Development Services Market Size (2017-2028)
8.2 Asia-Pacific Clinical Development Services Market Size by Type
8.2.1 Asia-Pacific Clinical Development Services Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Clinical Development Services Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Clinical Development Services Market Share by Type (2017-2028)
8.3 Asia-Pacific Clinical Development Services Market Size by Application
8.3.1 Asia-Pacific Clinical Development Services Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Clinical Development Services Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Clinical Development Services Market Share by Application (2017-2028)
8.4 Asia-Pacific Clinical Development Services Market Size by Region
8.4.1 Asia-Pacific Clinical Development Services Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Clinical Development Services Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical Development Services Market Size (2017-2028)
9.2 Latin America Clinical Development Services Market Size by Type
9.2.1 Latin America Clinical Development Services Market Size by Type (2017-2022)
9.2.2 Latin America Clinical Development Services Market Size by Type (2023-2028)
9.2.3 Latin America Clinical Development Services Market Share by Type (2017-2028)
9.3 Latin America Clinical Development Services Market Size by Application
9.3.1 Latin America Clinical Development Services Market Size by Application (2017-2022)
9.3.2 Latin America Clinical Development Services Market Size by Application (2023-2028)
9.3.3 Latin America Clinical Development Services Market Share by Application (2017-2028)
9.4 Latin America Clinical Development Services Market Size by Country
9.4.1 Latin America Clinical Development Services Market Size by Country (2017-2022)
9.4.2 Latin America Clinical Development Services Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Development Services Market Size (2017-2028)
10.2 Middle East & Africa Clinical Development Services Market Size by Type
10.2.1 Middle East & Africa Clinical Development Services Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Clinical Development Services Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Clinical Development Services Market Share by Type (2017-2028)
10.3 Middle East & Africa Clinical Development Services Market Size by Application
10.3.1 Middle East & Africa Clinical Development Services Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Clinical Development Services Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Clinical Development Services Market Share by Application (2017-2028)
10.4 Middle East & Africa Clinical Development Services Market Size by Country
10.4.1 Middle East & Africa Clinical Development Services Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Clinical Development Services Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Syneos Health
11.1.1 Syneos Health Company Details
11.1.2 Syneos Health Business Overview
11.1.3 Syneos Health Clinical Development Services Introduction
11.1.4 Syneos Health Revenue in Clinical Development Services Business (2017-2022)
11.1.5 Syneos Health Recent Developments
11.2 PPD
11.2.1 PPD Company Details
11.2.2 PPD Business Overview
11.2.3 PPD Clinical Development Services Introduction
11.2.4 PPD Revenue in Clinical Development Services Business (2017-2022)
11.2.5 PPD Recent Developments
11.3 GVI CDS
11.3.1 GVI CDS Company Details
11.3.2 GVI CDS Business Overview
11.3.3 GVI CDS Clinical Development Services Introduction
11.3.4 GVI CDS Revenue in Clinical Development Services Business (2017-2022)
11.3.5 GVI CDS Recent Developments
11.4 Parexel
11.4.1 Parexel Company Details
11.4.2 Parexel Business Overview
11.4.3 Parexel Clinical Development Services Introduction
11.4.4 Parexel Revenue in Clinical Development Services Business (2017-2022)
11.4.5 Parexel Recent Developments
11.5 Clinical Leader
11.5.1 Clinical Leader Company Details
11.5.2 Clinical Leader Business Overview
11.5.3 Clinical Leader Clinical Development Services Introduction
11.5.4 Clinical Leader Revenue in Clinical Development Services Business (2017-2022)
11.5.5 Clinical Leader Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Clinical Development Services Introduction
11.6.4 Thermo Fisher Scientific Revenue in Clinical Development Services Business (2017-2022)
11.6.5 Thermo Fisher Scientific Recent Developments
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Clinical Development Services Introduction
11.7.4 LabCorp Revenue in Clinical Development Services Business (2017-2022)
11.7.5 LabCorp Recent Developments
11.8 Worldwide Clinical Trial
11.8.1 Worldwide Clinical Trial Company Details
11.8.2 Worldwide Clinical Trial Business Overview
11.8.3 Worldwide Clinical Trial Clinical Development Services Introduction
11.8.4 Worldwide Clinical Trial Revenue in Clinical Development Services Business (2017-2022)
11.8.5 Worldwide Clinical Trial Recent Developments
11.9 CROS NT
11.9.1 CROS NT Company Details
11.9.2 CROS NT Business Overview
11.9.3 CROS NT Clinical Development Services Introduction
11.9.4 CROS NT Revenue in Clinical Development Services Business (2017-2022)
11.9.5 CROS NT Recent Developments
11.10 Dynakin
11.10.1 Dynakin Company Details
11.10.2 Dynakin Business Overview
11.10.3 Dynakin Clinical Development Services Introduction
11.10.4 Dynakin Revenue in Clinical Development Services Business (2017-2022)
11.10.5 Dynakin Recent Developments
11.11 Rho, Inc.
11.11.1 Rho, Inc. Company Details
11.11.2 Rho, Inc. Business Overview
11.11.3 Rho, Inc. Clinical Development Services Introduction
11.11.4 Rho, Inc. Revenue in Clinical Development Services Business (2017-2022)
11.11.5 Rho, Inc. Recent Developments
11.12 Synteract
11.12.1 Synteract Company Details
11.12.2 Synteract Business Overview
11.12.3 Synteract Clinical Development Services Introduction
11.12.4 Synteract Revenue in Clinical Development Services Business (2017-2022)
11.12.5 Synteract Recent Developments
11.13 ICBio CRO
11.13.1 ICBio CRO Company Details
11.13.2 ICBio CRO Business Overview
11.13.3 ICBio CRO Clinical Development Services Introduction
11.13.4 ICBio CRO Revenue in Clinical Development Services Business (2017-2022)
11.13.5 ICBio CRO Recent Developments
11.14 Sofpromed
11.14.1 Sofpromed Company Details
11.14.2 Sofpromed Business Overview
11.14.3 Sofpromed Clinical Development Services Introduction
11.14.4 Sofpromed Revenue in Clinical Development Services Business (2017-2022)
11.14.5 Sofpromed Recent Developments
11.15 Profil
11.15.1 Profil Company Details
11.15.2 Profil Business Overview
11.15.3 Profil Clinical Development Services Introduction
11.15.4 Profil Revenue in Clinical Development Services Business (2017-2022)
11.15.5 Profil Recent Developments
11.16 ICON plc
11.16.1 ICON plc Company Details
11.16.2 ICON plc Business Overview
11.16.3 ICON plc Clinical Development Services Introduction
11.16.4 ICON plc Revenue in Clinical Development Services Business (2017-2022)
11.16.5 ICON plc Recent Developments
11.17 Clinipace
11.17.1 Clinipace Company Details
11.17.2 Clinipace Business Overview
11.17.3 Clinipace Clinical Development Services Introduction
11.17.4 Clinipace Revenue in Clinical Development Services Business (2017-2022)
11.17.5 Clinipace Recent Developments
11.18 OCT Clinical
11.18.1 OCT Clinical Company Details
11.18.2 OCT Clinical Business Overview
11.18.3 OCT Clinical Clinical Development Services Introduction
11.18.4 OCT Clinical Revenue in Clinical Development Services Business (2017-2022)
11.18.5 OCT Clinical Recent Developments
11.19 EPS Group
11.19.1 EPS Group Company Details
11.19.2 EPS Group Business Overview
11.19.3 EPS Group Clinical Development Services Introduction
11.19.4 EPS Group Revenue in Clinical Development Services Business (2017-2022)
11.19.5 EPS Group Recent Developments
11.20 Beijing Sun-novo Pharmaceutical Research
11.20.1 Beijing Sun-novo Pharmaceutical Research Company Details
11.20.2 Beijing Sun-novo Pharmaceutical Research Business Overview
11.20.3 Beijing Sun-novo Pharmaceutical Research Clinical Development Services Introduction
11.20.4 Beijing Sun-novo Pharmaceutical Research Revenue in Clinical Development Services Business (2017-2022)
11.20.5 Beijing Sun-novo Pharmaceutical Research Recent Developments
11.21 Dmedglobal
11.21.1 Dmedglobal Company Details
11.21.2 Dmedglobal Business Overview
11.21.3 Dmedglobal Clinical Development Services Introduction
11.21.4 Dmedglobal Revenue in Clinical Development Services Business (2017-2022)
11.21.5 Dmedglobal Recent Developments
11.22 WuXi AppTec
11.22.1 WuXi AppTec Company Details
11.22.2 WuXi AppTec Business Overview
11.22.3 WuXi AppTec Clinical Development Services Introduction
11.22.4 WuXi AppTec Revenue in Clinical Development Services Business (2017-2022)
11.22.5 WuXi AppTec Recent Developments
11.23 Elixir Clinical Research
11.23.1 Elixir Clinical Research Company Details
11.23.2 Elixir Clinical Research Business Overview
11.23.3 Elixir Clinical Research Clinical Development Services Introduction
11.23.4 Elixir Clinical Research Revenue in Clinical Development Services Business (2017-2022)
11.23.5 Elixir Clinical Research Recent Developments
11.24 IBM
11.24.1 IBM Company Details
11.24.2 IBM Business Overview
11.24.3 IBM Clinical Development Services Introduction
11.24.4 IBM Revenue in Clinical Development Services Business (2017-2022)
11.24.5 IBM Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • CD47（IAP）の世界市場インサイト・予測（～2028年）
  • 高速溶解口腔薄膜（OTF）の世界市場インサイト・予測（～2028年）
  • 持続携行式腹膜透析（CAPD）の世界市場インサイト・予測（～2028年）
  • 頸部胸部オルソシス（CTO）の世界市場インサイト・予測（～2028年）
  • 心臓血管情報システム（CVIS）の世界市場インサイト・予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QY22JL3855 )"臨床開発サービス（CDS）の世界市場インサイト・予測（～2028年）" (英文：Global Clinical Development Services Market Insights, Forecast to 2028)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。